Skip to main content
TipRanks
Go Ultimate75% OFF

WFE Technology Corp. (6474) AI Stock Analysis

TW:6474

WFE Technology Corp.

(TPEx:6474)

Select Model
Rating:62Neutral
Price Target:TWD 36.00â–²(1.27% Upside)
Action:initiatedcoverage
Date:11/09/26

Strong balance sheet and attractive valuation with high yield are the main positive drivers, while declining revenues, cash flow volatility, and bearish technical signals weigh on the overall score.

Positive Factors
Improving ProfitabilityHigher gross and net margins indicate that the company retained more value from each unit of revenue in 2025 than during the weak 2023 period. If sustained, this improvement can strengthen earnings quality, support reinvestment, and provide greater resilience against operating volatility.
Negative Factors
Revenue ContractionThe recent revenue decline shows that improved profitability has not yet been supported by dependable top-line expansion. Continued uneven demand would limit operating leverage, make margin progress harder to sustain, and constrain the company’s ability to compound earnings over the next several quarters.

WFE Technology Corp. (6474) vs. SPDR S&P 500 ETF (SPY)

-15%-10%-5%0%5%10%15%20%TW:6474-1.56%SPY+14.30%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
TWD 1.87B
Dividend Yield
7.03%
Average Volume (3M)
50.71K
Price to Earnings (P/E)
12.3
Beta (1Y)
0.25
Revenue Growth
―
EPS Growth
―
Country
TW
Employees
470
Sector
General
Sector Strength
55
Industry
Hardware, Equipment & Parts

WFE Technology Corp. Business Overview & Revenue Model

Company Description

WFE Technology Corporation, a Taiwan-based enterprise, specializes in the development and sale of a diverse range of electronic products. Its comprehensive product lineup features items such as pressure sensors, hybrid protection components, and high...

WFE Technology Corp. Financial Statement Overview

Summary

Improved gross and net margins alongside substantial debt reduction strengthening the balance sheet, though offset by declining revenues and volatile cash flows.

Income Statement

63Positive

Balance Sheet

87Very Positive

Cash Flow

42Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue3.06B3.85B4.09B4.03B4.34B4.41B
Gross Profit662.04M856.46M784.60M656.22M848.64M804.44M
EBITDA221.17M303.01M258.10M187.36M315.83M342.41M
Net Income144.72M164.96M122.14M34.96M167.19M233.34M
Balance Sheet
Total Assets3.49B3.19B3.08B3.25B3.93B2.83B
Cash, Cash Equivalents and Short-Term Investments381.75M263.65M233.04M249.21M284.88M384.58M
Total Debt955.24M885.01M990.31M1.33B2.07B1.24B
Total Liabilities1.80B1.49B1.62B1.91B2.57B1.77B
Stockholders Equity1.69B1.70B1.46B1.34B1.36B1.05B
Cash Flow
Free Cash Flow-82.44M71.47M403.95M758.27M-994.83M54.41M
Operating Cash Flow-71.40M104.28M420.45M769.97M-954.72M72.43M
Investing Cash Flow-8.97M-21.85M-438.00K41.54M-80.57M-21.04M
Financing Cash Flow77.33M-37.26M-418.11M-794.61M897.08M-28.23M

WFE Technology Corp. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

TW:6474 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TW:4911TW:491172OutperformTWD 1.74B18.66―4.66%-26.73%-34.96%
TW:6666TW:666668NeutralTWD 1.93B12.30―4.83%7.96%39.74%
TW:6474TW:647462NeutralTWD 1.81B12.26―7.03%――
TW:4148TW:414860NeutralTWD 1.96B10.66―3.40%15.66%31.51%
TW:1295TW:129559NeutralTWD 1.58B10.17―7.14%-5.28%-27.33%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

-40%-20%0%TW:6474TW:1295TW:4148TW:4911TW:6666TW:7837Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TW:6474 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TW:6474WFE Technology Corp.35.55-1.03-2.82%
TW:1295Synbio Tech Inc41.90-49.75-54.28%
TW:4148All Cosmos Bio-Tech Holding Corp.29.40-11.51-28.13%
TW:4911G&E Herbal Biotechnology Co., Ltd.25.00-18.42-42.42%
TW:6666Luo Lih-Fen Holding Co., Ltd.41.45-5.20-11.15%
TW:7837Creative Life Science Co Ltd73.40-37.89-34.05%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 09, 2026